NSE filing, NSE: RNFI. Summary written from the filing by ALFA Finder's alert engine.
RNFI Services Ltd: key numbers
- Share price
- ₹325.00
- Market cap
- ₹825.3 Cr
- Revenue (annual)
- ₹968.6 Cr
- Net profit (annual)
- ₹28.98 Cr
- P/E (TTM)
- 28.5×Sector 19.7×
- Promoter holding
- 64.25%-0.10% QoQ
- FII holding
- 1.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from RNFI Services Ltd
All →RNFI Services Annual General Meeting
RNFI Services announced passage of a resolution via postal ballot, per the scrutinizer's report dated 26 October 2026. Voting results and the scrutinizer's report were filed with NSE.
RNFI Services Legal & Regulatory
RNFI Services Limited received a favorable appellate order from the Income Tax authorities, deleting a tax addition of Rs. 1.48 Crore for AY 2024-25.
- Value
- ₹1.48 Cr
RNFI Services Acquisition Worth ₹12 Cr
RNFI Services Limited will acquire business correspondent undertakings from Arth Rural Connect and AgroServe Global for a maximum aggregate consideration of ₹12 Crore on a slump sale basis.
- Value
- ₹12.00 Cr
- From
- Arth Rural Connect Services Private Limited and AgroServe Global Technologies Private Limited
- Execution
- Within 90 days
RNFI Services Annual General Meeting
RNFI Services Limited has issued a Postal Ballot Notice to seek shareholder approval for altering its Memorandum of Association's object clause.
RNFI Services Adverse Business Impact
RNFI Services Limited reported a fire incident at its registered office on September 23, 2026. No injuries occurred, and business operations continue without disruption.
RNFI Services Bags New Order from Chhattisgarh Gramin Bank
RNFI Services Limited has been appointed as a Corporate Business Correspondent by Chhattisgarh Gramin Bank to provide various banking and financial services.
- From
- Chhattisgarh Gramin Bank
- Execution
- 12 months
Other regulatory approval announcements
All →Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.
Kalyani Cast-Tech Regulatory Approval
Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.
Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Canara Bank Regulatory Approval
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
- Value
- ₹1,500 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.